Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins

Archives of Surgery

Volumn 141, Issue 7, 2006, Pages 663-669

  Stamou, Konstantinos M ^a,c   Toutouzas, Konstantinos G ^a   Kekis, Panagiotis B ^a   Nakos, Socrates ^b   Gafou, Anthippi ^b   Manouras, Andreas ^a   Krespis, Eustathios ^a   Katsaragakis, Stylianos ^a   Bramis, John ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HIPPOKRATION HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; FIBRINOGEN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BLOOD CLOTTING TEST; COLOR ULTRASOUND FLOWMETRY; CONGENITAL DISORDER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MESENTERIC VEIN; MESENTERIC VEIN THROMBOSIS; PORTAL VEIN; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SPLENECTOMY; SPLENIC VEIN; SPLENOMEGALY; THROMBOCYTOSIS; THROMBOPHILIA; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MESENTERIC VEINS; MIDDLE AGED; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS; SPLENECTOMY; SPLENIC VEIN; THROMBOCYTOSIS; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 33746035331     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.141.7.663     Document Type: Article

References (44)

1. van't Riet M, Burger JW, van Muiswinkel JM, Kazemier G, Schipperus MR, Bonjer HJ. Diagnosis and treatment of portal vein thrombosis following splenectomy. Br J Surg. 2000;87:1229-1233.
2. Chaffanjon PC, Brichon PY, Ranchoup Y, Gressin R, Sotto JJ. Portal vein thrombosis following splenectomy for hematologic disease: prospective study with Doppler colour flow imaging. World J Surg. 1998;22:1082-1086.
3. Hassn AM, Al-Fallouji MA, Ouf TI, Saad R. Portal vein thrombosis following splenectomy. Br J Surg. 2000;87:362-373.
4. American College of Chest Physicians. Proceedings of the 5th Consensus Conference on Antithrombotic Therapy (1998): summary recommendations. Chest. 1998;114(suppl):739S-769S.
5. Beeckman Delatour M. Thrombosis of the mesenteric veins as a cause of death after splenectomy. Ann Surg. 1895;21:24-28.
6. Fujitani K, Nishiyama A, Tsujinaka T, Hirao M, Hasuike Y, Takeda Y. Portal vein thrombosis after splenectomy for gastric malignant lymphoma. Gastric Cancer. 2003;6:250-254.
7. Olson MM, Ilada PB, Apelgren KN. Portal vein thrombosis. Surg Endosc. 2003;17:1322.
8. Brink JS, Brown AK, Palmer BA, Moir C, Rodeberg DR. Portal vein thrombosis after laparoscopy-assisted splenectomy and cholecystectomy. J Pediatr Surg. 2003;38:644-647.
9. Parker HH III, Bynoe RP, Nottingham JM. Thrombosis of the portal venous system after splenectomy for trauma. J Trauma. 2003;54:193-196.
10. Fujita F, Lyass S, Otsuka K, et al. Portal vein thrombosis following splenectomy: identification of risk factors. Am Surg. 2003;69:951-956.
11. Petit P, Bret PM, Atri M, Hreno A, Casola G, Gianfelice D. Splenic vein thrombosis after splenectomy: frequency and role of imaging. Radiology. 1994;190:65-68.
12. Ponzano C, Nardi S, Carrieri P, Basili G. Massive thrombosis of the superior mesenteric artery following splenectomy: a coincidence? [in Italian] Minerva Chir. 1999;54:437-441.
13. Lee JJ, Kim HJ, Chung IJ, et al. Portal, mesenteric, and splenic vein thromboses after splenectomy in a patient with chronic myeloid leukemia variant with thrombocythemic onset. Am J Hematol. 1999;61:212-215.
14. Simpson WG, Schwartz RW, Strodel WE. Splenic vein thrombosis. South Med J. 1990;83:417-421.
15. Randi ML, Fabris F, Ruzzon E, Pacquola E, Cella G, Girolami A. Splenectomy after portal thrombosis in patients with polycythemia vera and essential thrombocythemia. Haematologica. 2002;87:1180-1184.
16. Eguchi A, Hashizume M, Kitano S, Tanoue K, Wada H, Sugimachi K. High rate of portal thrombosis after splenectomy in patients with esophageal varices and idiopathic portal hypertension. Arch Surg. 1991;126:752-755.
17. Crossin JD, Muradali D, Wilson SR. US of liver transplants: normal and abnormal. Radiographics. 2003;23:1093-1114.
18. Marshall MM, Beese RC, Muiesan P, Sarma DI, O'Grady J, Sidhu PS. Assessment of portal venous system patency in the liver transplant candidate: a prospective study comparing ultrasound, microbubble-enhanced colour Doppler ultrasound, with arteriography and surgery. Clin Radiol. 2002;57:377-383.
19. Ricci P, Cantisani V, Biancari F, et al. Contrast-enhanced color Doppler US in malignant portal vein thrombosis. Acta Radiol. 2000;41:470-473.
20. Bach AM, Hann LE, Brown KT, et al. Portal vein evaluation with US: comparison to angiography combined with CT arterial portography. Radiology. 1996;201:149-154.
21. Rodgers PM, Ward J, Baudouin CJ, Ridgway JP, Robinson PJ. Dynamic contrast-enhanced MR imaging of the portal venous system: comparison with x-ray angiography. Radiology. 1994;191:741-774.
22. Kreft B, Strunk H, Flacke S, et al. Detection of thrombosis in the portal venous system: comparison of contrast-enhancedMRangiography with intraarterial digital subtraction angiography. Radiology. 2000;216:86-92.
23. Kuszyk BS, Osterman FA Jr, Venbrux AC, et al. Portal venous system thrombosis: helical CT angiography before transjugular intrahepatic portosystemic shunt creation. Radiology. 1998;206:179-186.
24. Finn JP, Kane RA, Edelman RR, et al. Imaging of the portal venous system in patients with cirrhosis: MR angiography vs duplex Doppler sonography. AJR Am J Roentgenol. 1993;161:989-994.
25. Rattner DW, Ellman L, Warshaw AL. Portal vein thrombosis after elective thrombosis: an underappreciated, potentially lethal syndrome. Arch Surg. 1993;128:565-570.
26. Broe PJ, Conley CL, Cameron JL. Thrombosis of the portal vein following splenectomy for myeloid metaplasia. Surg Gynecol Obstet. 1981;152:488-492.
27. Sheen CL, Lamparelli H, Milne A, Green I, Ramage JK. Clinical features, diagnosis and outcome of acute portal vein thrombosis. QJM. 2000;93:531-534.
28. Kakkar VV, Gebska M, Kadziola Z, Saba N, Carrasco P; Bemiparin Investigators. Low-molecular-weight heparin in the acute and long-term treatment of deep vein thrombosis. Thromb Haemost. 2003;89:674-680.
29. Bergqvist D, Agnelli G, Cohen AT, et al; ENOXACAN II Investigators. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346:975-980.
30. Resende V, Petroianu A. Functions of the splenic remnant after subtotal splenectomy for treatment of severe splenic injuries. Am J Surg. 2003;185:311-315.
31. Heijboer H, Brandjes DP, Buller HR, Sturk A, ten Cate JW. Deficiencies of coagulation inhibiting and fibrinolytic proteins in outpatients with DVT. N Engl J Med. 1990;323:1512-1516.
32. Shirahata A, Funahara Y, Opartkiattikul N, Fucharoen S, Laosombat V, Yamada K. Protein C and protein S deficiency in thalassemic patients. Southeast Asian J Trop Med Public Health. 1992;23:65-73.
33. Yang YY, Chan CC, Wang SS, et al. Case report: portal vein thrombosis associated with hereditary protein C deficiency: a report of two cases. J Gastroenterol Hepatol. 1999;14:1119-1123.
34. Pabinger I, Kyrle PA, Heistinger M, Eichinger S, Wittmann E, Lechner K. The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency: a prospective cohort study. Thromb Haemost. 1994;71:441-445.
35. Perrier A, Desmarais S, Miron MJ, et al. Noninvasive diagnosis of venous thromboembolism in outpatients. Lancet. 1999;353:190-195.
36. Bates SM, Grand'Maison A, Johnston M, Naguit I, Kovacs MJ, Ginsberg JS. A latex D-dimer reliably excludes venous thromboembolism. Arch Intern Med. 2001;161:447-453.
37. Shorr AF, Thomas SJ, Alkins SA, Fitzpatrick TM, Ling GS. D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients. Chest. 2002;121:1262-1268.
38. Kinasewitz GT, Yan SB, Basson B, et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism. Crit Care. 2004;8:R82-R90.
39. Hirsh J, Dalen J, Guyatt G; American College of Chest Physicians. The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Chest Physicians. Chest. 2001;119(1 suppl):1S-2S.
40. Bilbao JI, Rodriguez-Cabello J, Longo J, Zornoza G, Paramo J, Lecumberri FJ. Portal thrombosis: percutaneous transhepatic treatment with urokinase, a case report. Gastrointest Radiol. 1989;14:326-328.
41. Suzuki S, Nakamura S, Baba S, et al. Portal vein thrombosis after splenectomy successfully treated by an enormous dosage of fibrinolytic agent in a short period: report of two cases. Surg Today. 1992;22:464-469.
42. Kunin N, Desjardins JF, Letoquart JP, La Gamma A, Lebois E, Mambrini A. Mesenteric-portal thrombosis after hematologic splenectomy [in French]. J Chir (Paris). 1996;133:453-458.
43. Kercher KW, Sing RF, Watson KW, Matthews BD, LeQuire MH, Heniford BT. Transhepatic thrombolysis in acute portal vein thrombosis after laparoscopic splenectomy. Surg Laparosc Endosc Percutan Tech. 2002;12:131-136.
44. Ginsberg JS, Wells PS, Kearon C, et al. Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolism. Ann Intern Med. 1998;129:1006-1011.